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  EVIDENCE-BASED ANSWER 
Short-acting hypnotics such as zolpidem (Ambien) or zaleplon (Sonata) are the preferred hypnotics in the 
elderly because of an improved side-effect profile compared with traditional hypnotics such as 
benzodiazepines (strength of recommendation: B, based on extrapolations of randomized controlled trials). 
Zolpidem and zaleplon have a quick onset and short duration of action, making them less likely to cause 
residual sedation, cognitive changes, and falls than benzodiazepines. More comparative clinical trials in the 
elderly are needed to determine if zolpidem and zaleplon are truly safer than benzodiazepines in this 
population. Hypnotics should be prescribed on a short-term, intermittent basis as part of a comprehensive 
treatment plan that addresses any underlying causes of poor sleep. 
  EVIDENCE SUMMARY 
Zolpidem and zaleplon 
Zolpidem and zaleplon differ structurally from benzodiazepines but act at the benzodiazepine receptor.1 Due to 
their rapid absorption and short half-lives, they are particularly helpful for patients who have trouble falling 
asleep.2 They have been shown to decrease sleep latency, increase total sleep time, and increase sleep 
efficiency without disturbing sleep architecture or adversely affecting memory.1 
Comparative studies in the elderly have demonstrated that zolpidem is as effective as triazolam,3 and that 
zaleplon is more effective than placebo at decreasing sleep latency and improving sleep quality.4 Tolerance, 
withdrawal symptoms, or rebound insomnia occur less frequently than with benzodi-azepines,1 but zolpidem 
increased risk of hip fracture in a case control study (adjusted odds ratio=1.95, 95% confidence interval, 1.09–
3.51).5 
Side effects of zolpidem and zaleplon are considered dose-related, and a lower dose of 5 mg is recommended 
for older patients.2 Efficacy of intermittent use of zolpidem has been demonstrated in clinical studies,1 a 
practice that could potentially decrease risk of side effects. Overall, if a hypnotic is desired for an older adult, 
zolpidem and zaleplon are preferred because of their improved side-effect profiles compared with older 
hypnotics such as benzodiazepines, chloral hydrate, over-the-counter sleep aids, and antidepressants (see 
Table ). 
 
TABLE 1 
Adverse effects of hypnotics in the elderly 
Hypnotic Adverse effect 
Benzodiazepines 
Somnolence, anterograde amnesia, falls, hip fracture, 
rebound insomnia, tolerance, dependence, impaired 
sleep architecture2,3,5 
Antihistamines 
Somnolence, dry mouth, constipation, urinary retention, 
blurred vision, cognitive changes3 
Valerian 
Headache, excitability, uneasiness, cardiac disturbances, 
insomnia, drowsiness, withdrawal symptoms10 
Melatonin 
Headache, depressive symptoms, daytime fatigue and 
drowsiness, dizziness, abdominal cramps, reduced 
alertness10 
Chloral hydrate 
Nausea, vomiting, diarrhea, may increase effects of 
warfarin, overdose potential3,8 
Tricyclic 
antidepressants 
Dry mouth, constipation, urinary retention, blurred vision, 
cognitive changes, orthostatic hypotension, somnolence, 
worsening of chronic heart failure, overdose potential, 
cardiac conduction abnormalities2,3 
Trazodone 
Somnolence, orthostatic hypotension, dry mouth, 
priapism3 
Zolpidem 
Drowsiness, headache, dizziness, somnolence, fatigue, 
agitation, nightmares, diarrhea, myalgia, arthralgia, 
anterograde amnesia1,10 
Zaleplon 
Headache, dizziness, somnolence, short-term amnesic 
effects, next-day memory impairment, mild rebound 
insomnia1,10 
Benzodiazepines 
Benzodiazepines have been used since the 1960s for their hypnotic, anxiolytic, anticonvulsant, muscle-
relaxing, and amnesic properties. A recent meta-analysis showed that benzodiazepines improve sleep latency 
by only 4.2 minutes compared with placebo.6 Although benzodiazepines increase sleep time and efficiency, 
patients quickly develop tolerance to the hypnotic effects.7 Additional problems associated with 
benzodiazepines include dependence, rebound insomnia, residual sedation, falls, hip fractures, and 
detrimental effects on sleep architecture.7 
Chloral hydrate 
Chloral hydrate has a narrow therapeutic index and is not recommended for the treatment of insomnia.8 
Tolerance to its effects develops after only 2 weeks of use, and drug interactions with warfarin can occur.2 
Over-the-counter sleep aids 
Most over-the-counter sleep aids contain diphen-hydramine, a long-acting antihistamine that is considered less 
effective than benzodiazepines. The anticholinergic properties of antihistamines can result in cognitive changes 
and urinary retention in the elderly.8 Melatonin and valerian are “natural” hypnotics that are available without a 
prescription,9 but their safety and efficacy are not regulated by the FDA.8 
Antidepressants 
Antidepressants with sedative effects, such as tricyclic antidepressants and trazodone, have been used for 
insomnia, but minimal data support the efficacy or safety of this approach.8 Tricyclic antidepressants may 
exacerbate restless legs syndrome and periodic limb movement disorder,8 cause anticholinergic side effects, 
worsen chronic heart failure, and cause ortho-static hypotension and falls.2 Although tra-zodone is not a 
tricyclic antidepressant, it can cause dry mouth, orthostatic hypotension, and (rarely) priapism.2 
  RECOMMENDATIONS FROM OTHERS 
A Canadian consensus statement published in 2003 supports the use of non-benzodiazepines such as 
zolpidem and zaleplon due to improved tolerability, and less withdrawal and abuse potential compared with 
benzodiazepines.7 The National Heart, Lung and Blood Institute Working Group on Insomnia recommends the 
use of short-acting hypnotics for short-term management of insomnia, but does not differentiate between short-
acting benzodiazepines and the newer hypnotics such as zolpidem and zale-plon.8 Geriatric experts 
recommend that long-acting benzodiazepines, barbiturates, and amitriptyline be avoided in the elderly due to 
the risk of adverse drug events.10 
CLINICAL COMMENTARY 
Question the patient about sleep habits 
 
David  Cravens,  MD, MSPH 
Department of Family & Community Medicine, University of Missouri–Columbia 
Sleep complaints are common in the elderly. However, before prescribing a hypnotic, 
determine the elderly patient’s sleep habits: often daytime naps plus nighttime sleep add 
up to adequate sleep. Encourage measures to avoid daytime naps if nighttime sleep is 
more important. Second, discuss sleep hygiene, such as avoiding evening caffeine or 
excessive alcohol, and avoiding using bed for activities other than sleeping, such as 
watching TV, reading, and the like. Determine whether sleep problems are part of a larger 
problem requiring evaluation, such as medication effects, depression, or obstructive sleep 
apnea. Finally, consider costs: although not a true hypnotic, trazodone at doses of 25–50 
mg is a very effective and well-tolerated soporific at about one-tenth the cost of 5 mg of 
zolpidem or zaleplon. 
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